Your session is about to expire
← Back to Search
Behavioural Intervention
HabitAware Keen2 for Trichotillomania
N/A
Recruiting
Led By Joseph McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
able to attend three study visits;
18 years of age or older;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
Study Summary
This trial will study the Keen 2, a device meant to increase awareness of hair-pulling behavior, to see if it reduces the severity of hair-pulling and related symptoms.
Who is the study for?
This trial is for adults over 18 with Trichotillomania (TTM), who can wear the Keen2 device for four weeks and attend three study visits. Participants should have a stable dose of psychiatric medication, if any, speak English, and score high enough on specific tests measuring TTM severity.Check my eligibility
What is being tested?
The trial is testing the Keen2 device's effectiveness in increasing awareness of hair-pulling behaviors in people with TTM. It aims to see if this leads to a reduction in automatic pulling behavior and improves related psychiatric symptoms.See study design
What are the potential side effects?
Since the Keen2 is a non-invasive wearable device designed to increase self-awareness rather than deliver medication or therapy, it may not have typical side effects but could cause skin irritation or discomfort from wearing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can attend three study visits.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version
Secondary outcome measures
Massachusetts General Hospital Hair Pulling Scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: HabitAware Keen 2Experimental Treatment1 Intervention
Participants will receive the wrist device device that alerts the participant when the participant is engaging in hair pulling behavior.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,266 Previous Clinical Trials
14,837,457 Total Patients Enrolled
Joseph McGuire, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can attend three study visits.I cannot attend the study visits.I have been on a stable dose of psychiatric medication for at least 8 weeks.have a MGH-HPS total score ≥ 12 at baseline;
have a MGH-HPS total score ≥ 12 at baseline;
have a MGH-HPS total score ≥ 12 at baseline;
have a MGH-HPS total score ≥ 12 at baseline.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: HabitAware Keen 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Trichotillomania Patient Testimony for trial: Trial Name: NCT05003401 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the enrollment capacity of this trial?
"That is accurate. According to the information present on clinicaltrials.gov, this trial was launched on November 17th 2021 and recently updated in September 7th 2022; it needs 40 participants from 1 medical centre for its completion."
Answered by AI
Is this research endeavor still taking on new participants?
"According to the clinicaltrials.gov page, this study is actively enrolling patients. The posting of the trial was on November 17th 2021 and has since been updated for a final time as of September 7th 2022."
Answered by AI
Who else is applying?
What state do they live in?
Florida
New York
Illinois
Other
How old are they?
18 - 65
What site did they apply to?
Johns Hopkins University School of Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
1
3+
Why did patients apply to this trial?
I want to try something to help me with this condition, I'm exhausted. I spend hundreds a month to get false eyelashes to try and hide my lack of lashes. I’ve found no relief from any treatment.
PatientReceived no prior treatments
I have suffered since I was 14. I have tried several drugs which helped for a few weeks but then the effectiveness dissipated. It would be wonderful to find something that works so that others can benefit.
PatientReceived 2+ prior treatments
What questions have other patients asked about this trial?
Can this be done without traveling? How long is the trial? What are the eligibility criteria?
PatientReceived 1 prior treatment
How responsive is this trial?
Most responsive sites:
- Johns Hopkins University School of Medicine: < 48 hours
Average response time
- < 2 Days
Typically responds via
Phone Call
Email
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger